Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Org_26576> ?p ?o. }
Showing items 1 to 29 of
29
with 100 items per page.
- Org_26576 abstract "Org 26576 is an ampakine drug originally developed by Cortex Pharmaceuticals and then licensed to Organon International for development. In animal studies it has been shown to effectively potentiate AMPA receptor function, leading to increased BDNF release and enhanced neuronal differentiation and survival, as well as producing nootropic effects in standardised assays.".
- Org_26576 iupacName "[9aS]-8,9,9a,10-tetrahydro-5H,7H-pyrido[3,2-f]pyrrolo[2,1-c][1,4]oxazepin-5-one".
- Org_26576 thumbnail Org26576_structure.png?width=300.
- Org_26576 wikiPageID "33938507".
- Org_26576 wikiPageRevisionID "546265087".
- Org_26576 c "11".
- Org_26576 h "12".
- Org_26576 hasPhotoCollection Org_26576.
- Org_26576 iupacName "[9aS]-8,9,9a,10-tetrahydro-5H,7H-pyrido[3,2-f]pyrrolo[2,1-c][1,4]oxazepin-5-one".
- Org_26576 legalStatus "Investigational New Medicine".
- Org_26576 molecularWeight "204.225".
- Org_26576 n "2".
- Org_26576 o "2".
- Org_26576 smiles "c23cccnc2OCC1CCCN1C3=O".
- Org_26576 width "220".
- Org_26576 subject Category:AMPA_receptor_modulators.
- Org_26576 subject Category:Ampakines.
- Org_26576 type Drug.
- Org_26576 type FunctionalSubstance.
- Org_26576 comment "Org 26576 is an ampakine drug originally developed by Cortex Pharmaceuticals and then licensed to Organon International for development. In animal studies it has been shown to effectively potentiate AMPA receptor function, leading to increased BDNF release and enhanced neuronal differentiation and survival, as well as producing nootropic effects in standardised assays.".
- Org_26576 label "Org 26576".
- Org_26576 label "Org 26576".
- Org_26576 sameAs Org_26576.
- Org_26576 sameAs m.0hnb9gk.
- Org_26576 sameAs Q5642889.
- Org_26576 sameAs Q5642889.
- Org_26576 wasDerivedFrom Org_26576?oldid=546265087.
- Org_26576 depiction Org26576_structure.png.
- Org_26576 isPrimaryTopicOf Org_26576.
